II. Management: General Pointers
- Follow a stepped strategy of Migraine medication
- Consider abortive agent sparing measures
- See Headache General Measures
- See Migraine Prophylaxis
- Establish Migraine Management Clinic Schedule
- Consider Migraine Headache Prophylaxis
- Frequent Migraine Headaches (4/month, 8 days/month)
- Prolonged Headaches >2 days with Disability
- Debilitating Headache despite acute Migraine abortive agents
- Intolerance or contraindications to acute Migraine abortive agents
- Analgesic Overuse Headaches or overuse of acute Migraine abortive agents
- Complicated Migraine Headache subtypes with prominent neurologic findings
- Evaluate acute Headache regimen with standardized symptom score
- Avoid overuse of abortive agents
- Frequent use results in Rebound Headache
- Limit Analgesics and NSAIDs to 3 days per week and 10 days per month
- Limit Triptans and combined Analgesics to 2 days per week and 8 days per month
- Most medications (e.g. Triptans, NSAIDs) are not effective in the prodrome or aura phase of Migraine Headache
- However, Ubrogepant (Ubrelvy, CGRP receptor blocker) may be effective during this phase
- Recurrent Migraine Headache within first 48 hours (40% of patients)
- See Emergency Department Migraine Headache Care
- Repeat dose of Triptan
- Combine Triptan with a longer acting Triptan
- Consider longer acting Triptans (e.g. Naratriptan, Frovatriptan)
- May have reduced initial efficacy (slower onset)
- Adjust management for specific cohorts
- Children
- Pregnancy and Lactation
- Older adults
- Acetaminophen (limit to <3 grams/day)
- Use NSAIDS only with caution (avoiding in most patients age >65-70 years)
- Triptans may be used if no significant vascular disease history
- Consider Gepants (review potential Drug Interactions, including with CYP3A4 inducers)
III. Medications: Serotonin Agonists
- See Acute Migraine Headache
-
Triptans may have inadequate response in up to one third of Migraine Headache patients
- Triptans may be less effective in Menstrual Migraine and sleep onset Migraine
- Improving Triptan efficacy
- Efficacy of a given Triptan is based on its success of treating 3-4 consecutive Migraine Headaches
- Increasing Triptan dose may moderately improve effect with some Triptans
- Sumatriptan and Eletriptan may be more effective at higher dose
- Zolmitriptan efficacy does not appear to improve with dosing increase
- Consider Rebound Headache or other Headache Causes
- Consider third-line agents (see below)
- Triptans (far preferred, have replaced Ergotamines)
-
Ergotamines (do not use within 24 hours of Triptans)
- Rarely used in modern U.S. Migraine Management (largely replaced by Triptans)
- Low oral Bioavailability
- High risk for Medication Overuse Headache
- Common associated Nausea and Vomiting
- Serious adverse Drug Interaction risk
- Ergotamine Agents
- Rarely used in modern U.S. Migraine Management (largely replaced by Triptans)
IV. Medications: Oral Analgesics
- See Acute Migraine Headache
-
General
- Beware Rebound Headaches with the frequent use of most Analgesics
-
Analgesics with proven efficacy
- Excedrin Migraine (Acetaminophen, Aspirin, Caffeine)
- Aspirin 975 mg PO (with or without Metoclopramide)
- Midrin (Isometheptene, Dichloralphenazone, Tylenol)
- Dose: 2 stat at Headache onset
- Repeat 1 each hour prn
- Maximum: 5 pills per 12 hours, 20 pills per month
- Limit use to no more than 2 days per week
- Anaprox, Aleve (NaproxenSodium)
- Absorbed more rapidly than Naprosyn
- Initial Dose: 825 mg (Three 275 mg tablets)
- Repeat 220 to 550 mg every 3-4 hours
- Maximum: 1.5 grams per day (5 to 6 tablets per day)
- Combined therapies may be helpful in refractory cases
- Aspirin (or NSAID) and Metoclopramide
- Aspirin 975 mg PO (three 325 mg tablets)
- Metoclopramide (Reglan) 10 mg PO
- DHE and Vistaril Combination (rare use)
- Aspirin (or NSAID) and Metoclopramide
-
Analgesics to be avoided (low efficacy and higher risk)
- Cafergot (Ergotamine with Caffeine)
- Dose: 2 PO stat with Headache onset
- Repeat one tablet every half hour prn
- Maximum: 4 to 6 pills per day or 10 per week
- Fiorinal (ASA 325mg, Caffeine 40mg, Butalbital 50mg)
- Dose: 2 tablets at Headache onset
- Repeat one tablet every 4 to 6 hours prn
- Maximum: 5 pills per day or 15 per month
- Limit use to no more than 2 days per week
- Risk of Rebound Headaches with use more than 5 days per month
- Esgic or Fioricet (Tylenol, Caffeine, Butalbital)
- Same dosing recommendations and precautions as for Fiorinal
- Precaution: Pharmaceutical obfuscation alert
- Fioricet brand name capsules (Watson) as of 2014 will contain 300 mg Acetaminophen (at 4x the generic cost)
- Fioricet generic tablets will contain 325 mg Acetaminophen (making automatic substitution difficult)
- One more reason not to prescribe fioricet (other Migraine abortive agents are preferred)
- (2014) Presc Lett 21(3)
- Cafergot (Ergotamine with Caffeine)
V. Medications: DopamineAntagonist Antiemetics
- See Emergency Department Migraine Headache Care
-
Antiemetics may be very useful in abortive treatment
- Alleviate Nausea associated with Headache
- Sedation to allow rest despite Headache
- Anti-Dopaminergic effects are very effective in Migraine Headaches
-
Metoclopramide (Reglan)
- Mechanism
- Antiemetic
- Dopamine Antagonist effects on Migraine Headache
- Increases castrointestinal motility (and Analgesic absorption)
- Dose: 10 mg PO 20-30 minutes before pre-medication
- Extrapyramidal Side Effects
- Dystonic Reaction (especially in children)
- Mechanism
VI. Medications: ParenteralAnalgesics
- See Emergency Department Migraine Headache Care
- See Serotonin Agonists (Triptans) below
- See Opioids below (avoid if possible)
-
Ketorolac (Toradol)
- Dose: 30-60 mg IM
- May repeat 15-30 mg q6h
- Do not exceed 5 consecutive days of use
- May supplement with rectal Antiemetic
VII. Medications: Rectal Analgesics (indicated for Vomiting)
- Rectal Antiemetics
- Promethazine (Phenergan) 12.5 to 25 mg PR q4-6 hours
- Prochlorperazine (Compazine) 25 mg PR q12 hours
- Rectal Analgesics
- Indomethacin 50 mg, 1-2 PR at Headache onset
-
Serotonin Agonist
- Ergotamine tartrate (Wigraine) suppository
- Use Ergotamine with caution due to adverse effects
VIII. Medications: Third-line Agents
- Precautions
- Expensive agents ($85 per tablet in 2020)
- Half the efficacy of Triptans
- Indications
- Benefits
- Gepant (CGRP receptor blocker)
-
Ditan (Selective Serotonin 5-Hydroxytryptamine receptor 1F agonst or 5-HT1F Agonist)
- Schedule V due to euphoria and Hallucinations
- Lasmiditan (Reyvow)
IX. Medications: Opioids
- Generally avoid Opioids in chronic Headache Management
- Indications
- Patients failing every other non-Opioid therapy and Migraine Prophylaxis despite neurology Consultation
- Least desirable for Headache Management
- Non-specific for Headache
- Higher risk for Rebound Headache
- Addictive potential (Substance Misuse)
- Stadol-NS (Butorphanol)
- Addictive (Class IV regulated substance)
- High abuse potential
- Dosing
- Stadol 1 spray in one nostril, repeat hourly prn
- Maximum 4 sprays per day or 6 sprays per week
- Limit to 2 days per week
- Addictive (Class IV regulated substance)
X. Medications: Other Non-Pharmacologic Measures
- Greater Occipital Nerve Block
- Neuromodulatory Devices
- Noninvasive Vagus Nerve stimulation
- Remote electrical neuromodulation
- Avoid measures without strong evidence in acute Migraine Management
- Acupuncture
- Electrical Trigeminal Nerve stimulation
- Single-Pulse transcranial magnetic stimulation
XI. Contraindications: Vasocontrictors (e.g. Triptans, DHE)
- Contraindications to Vasoconstrictors (e.g. Triptan, DHE)
- Coronary Artery Disease
- Cerebrovascular Accident history
- Hemiplegic Migraines
- Basilar Migraines
- Pregnancy
- Alternative Non-Vasoconstrictive agents
- Excedrin Migraine (Acetaminophen, Aspirin, Caffeine)
- NSAIDS
- Dopamine Antagonists (e.g. Metoclopramide or Prochlorperazine)
- Gepant (CGRP receptor blocker, e.g. Ubrogepant, Rimegepant, Zavegepant)
- Ditan (e.g. Lasmiditan)
XII. References
- (1995) Med Lett Drugs Ther 37(943) [PubMed]
- Moore (1997) Am Fam Physician 56(8):2039-48 [PubMed]
- Jackson (1998) CMEA Internal Medicine Lecture,San Diego
- Noble (1997) Am Fam Physician 56(9):2279-86 [PubMed]
- Puledda (2024) Cephalgia 44(8): 3331024241252666 [PubMed]
- Wiley (2025) Am Fam Physician 111(4): 317-27 [PubMed]